1. Home
  2. FOLD vs ADX Comparison

FOLD vs ADX Comparison

Compare FOLD & ADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$9.92

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Logo Adams Diversified Equity Fund Inc.

ADX

Adams Diversified Equity Fund Inc.

HOLD

Current Price

$23.02

Market Cap

2.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOLD
ADX
Founded
2002
1840
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.7B
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
FOLD
ADX
Price
$9.92
$23.02
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$30.29
N/A
AVG Volume (30 Days)
4.6M
182.4K
Earning Date
11-04-2025
01-01-0001
Dividend Yield
N/A
6.68%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$598,704,000.00
N/A
Revenue This Year
$21.12
N/A
Revenue Next Year
$21.23
N/A
P/E Ratio
N/A
N/A
Revenue Growth
21.28
N/A
52 Week Low
$5.51
$14.94
52 Week High
$10.57
$19.57

Technical Indicators

Market Signals
Indicator
FOLD
ADX
Relative Strength Index (RSI) 64.67 52.01
Support Level $9.56 $22.48
Resistance Level $10.05 $23.85
Average True Range (ATR) 0.37 0.33
MACD -0.02 -0.03
Stochastic Oscillator 51.14 44.93

Price Performance

Historical Comparison
FOLD
ADX

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

About ADX Adams Diversified Equity Fund Inc.

Adams Diversified Equity Fund Inc is a diversified investment company. It is an internally managed closed-end fund whose investment objectives are the preservation of capital, the attainment of reasonable income from investments, and an opportunity for capital appreciation. It invests a majority of its assets in very liquid S&P 500 stocks, and has broad flexibility in the selection of stocks, but maintains a sector neutral approach. The fund has a diversified equity portfolio which consists of securities of companies from energy, consumer staples, information technology, financials, and other sectors.

Share on Social Networks: